© 2022 MJH Life Sciences and Contagion Live. All rights reserved.
© 2022 MJH Life Sciences™ and Contagion Live. All rights reserved.
Jenna E. Januszka, PharmD, is a post-graduate second-year HIV/infectious diseases pharmacy resident at the University of Illinois at Chicago College of Pharmacy.
September 19, 2022
Gender-affirming hormone therapy (GAHT) therapy consists of administration of exogenous hormones and suppression of endogenous hormone production, with the goal of obtaining characteristics more congruent with an individual’s gender identity. Here is a review of these therapies and consideration for PrEP and the risks associated with HIV in this diverse population.
Invasive Nontyphoidal Salmonellosis: An Antimicrobial-Resistant Foe
Antibiotic Stewardship in Outpatient Care
Rapid, Reliable Diagnostic and PoC Tests Are Requisite for “Test to Treat"
HCV Not Associated With Myocarditis Risks for Young HIV Patients